After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk